BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AAPMD - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AAPMD
X-ORIGINAL-URL:https://aapmd.org
X-WR-CALDESC:Events for AAPMD
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200609T210000
DTEND;TZID=America/New_York:20200609T220000
DTSTAMP:20260405T065851
CREATED:20200305T182913Z
LAST-MODIFIED:20200530T165549Z
UID:7264-1591736400-1591740000@aapmd.org
SUMMARY:Pneumopedics®: Introduction to Non-Surgical Upper Airway Remodeling
DESCRIPTION:Sleep disordered breathing ranges from upper airway resistance syndrome (UARS) to obstructive sleep apnea (OSA)\, and is a serious medical condition in both children and adults\, adversely affecting the upper airway and breathing during sleep.  Biomimetic oral appliance therapy\, which is FDA-registered/cleared\, differs from conventional palatal expansion as it is used to correct the nasopharyngeal airway through epigenetic midfacial redevelopment in combination with mandibular correction for the oropharyngeal airway\, in order to improve the upper airway in both children and adults.  Over 50 published studies have indicated that correction of sleep related breathing disorders is possible using the novel approach of Pneumopedics for non-surgical upper airway remodeling. \n\nWebinar Objectives \n\n\nRealize the correlation of craniofacial growth and development and upper airway adequacy\nAppreciate the principles of craniofacial epigenetics\nIntroduce the principles of non-surgical upper airway remodeling (Pneumopedics)\nGain preliminary knowledge of biomimetic oral appliance therapy\n\n\n\n\nProfessor G. Dave Singh is a US citizen who was born\, educated and trained in England\, UK. He holds three doctorates\, including Doctor of Dental Medicine (University of Newcastle\, UK – validated at the University of Puerto Rico\, USA); a Ph.D. in cleft palate development (University of Bristol\, UK)\, and a third Doctorate in Orthodontics (University of Dundee\, UK). Dr Singh was awarded a grant by the British Society for Developmental Biology (University of Oxford\, UK)\, and later\, he was appointed to the Board of Examiners\, Royal College of Surgeons of England. He was also Visiting Professor at: the University of Saskatchewan\, Canada; the University of Airlangga\, Indonesia; the University of Health Sciences\, Antigua; University Sains Malaysia\, Kelantan\, and Adjunct Professor\, Portland State University\, USA. On the basis of being an “outstanding professor” supported by Harvard University\, the University of Michigan\, and the University of Hawaii\, he was invited to relocate to the Center for Craniofacial Disorders\, USA where he led a NIH-funded program of clinical craniofacial research. Currently\, he is a Board Member of the American Sleep and Breathing Association\, Member of the World Sleep Society\, Academic Fellow of the World Federation of Orthodontists\, and Fellow of the International Association for Orthodontics\, where he was awarded prizes in 2005\, 2013 and 2014. He has published over 200 articles in the peer-reviewed medical\, dental and orthodontic literature\, has published 7 books/chapters\, and is currently finishing his new book entitled “Pneumopedics and craniofacial epigenetics”\, which focuses on craniofacial sleep medicine with a special interest in a curative approach to obstructive sleep apnea in both children and adults. He has lectured and presented his work at numerous medical\, dental and orthodontic conferences in North America\, Asia\, Europe\, Australia and Africa. Dr Singh was the Founder and Chief Executive Officer of BioModeling Solutions\, Inc.\, where he obtained 8 US patents\, 2 Canadian patents and 2 international patents. He also obtained FDA registrations and clearances for his patented family of biomimetic oral appliances known as the DNA appliance® system\, which was acquired by Vivos Therapeutics\, Inc.\, USA. Currently\, he is Founder and Chief Medical Officer\, Vivos Therapeutics\, Inc. Dr. Singh was the 2019 recipient of the US Invisible Disabilities Association award for ‘providing the possibility of healthy lives for millions living with illness\, pain and disability’. In 2020\, Dr Singh was given a lifetime achievement award as one of the world’s top 100 doctors in dentistry for his work on sleep apnea ‘exemplifying leadership\, excellence\, and entrepreneurship in service to humanity and the advancement of global health’. \n\n\n\n1 CE Credit to AAPMD Members \nRegister/Info
URL:https://aapmd.org/event/airway-remodeling
LOCATION:AAPMD – Webinar
CATEGORIES:AAPMD Webinars
END:VEVENT
END:VCALENDAR